Indications -- diabetes Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- diabetes

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Ian@SI	9/28/2007 5:29:06 PM
	Read Replies (1) of 278

Here's one PhIII trial participant's reaction to Liraglutide. Anyone know if L is wholly owned by Novo Nordisk? ... or is there a small cap play on its success. I strongly suspect that they have a major blockbuster in L. +++++++++++++++ I have had 3 months from hell ... trying to get used to the byetta - which I never managed to do - and spent time either incredibly sick from it or dealing with high blood sugar .... I finally get to see Dr xxxxxx this morning so will go on insulin starting today until liragutide makes it to the market within next couple of years hopefully. Ticks me off that they won't supply it on compassionate grounds when it works so great for me.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next